Lost in centrifugation: Accounting for transporter protein losses in quantitative targeted absolute proteomics

Drug Metabolism and Disposition

Volumn 42, Issue 10, 2014, Pages 1766-1772

  Harwood, Matthew D ^a,b   Russell, Matthew R ^c   Neuhoff, Sibylle ^b   Warhurst, Geoffrey ^a   Rostami Hodjegan, Amin ^b,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CERTARA UK LIMITED   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN;

ACCURACY; CELL FRACTIONATION; CELL MEMBRANE; CENTRIFUGATION; DRUG DISPOSITION; FRACTIONATION; HUMAN; IN VITRO STUDY; NONHUMAN; PREDICTION; PROTEIN DEPLETION; PROTEOMICS; REVIEW; ANIMAL; BIOLOGICAL MODEL; ISOLATION AND PURIFICATION; PROCEDURES;

ANIMALS; CELL FRACTIONATION; CENTRIFUGATION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; PROTEOMICS;

EID: 84907579228     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.114.058446     Document Type: Review

References (35)

1. Balogh LM, Kimoto E, Chupka J, Zhang H, and Lai Y (2012) Membrane protein quantification by peptide-based mass spectrometry approaches: studies on the organic anion-Transporting polypeptide family. Proteomics &Bioinformatics 54:1-5.
2. Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, and Pelkonen OR, et al. (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 8:33-45.
3. Barter ZE, Chowdry JE, Harlow JR, Snawder JE, Lipscomb JC, and Rostami-Hodjegan A (2008) Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling. Drug Metab Dispos 36:2405-2409.
4. Blitzer BL and Donovan CB (1984) A new method for the rapid isolation of basolateral plasma membrane vesicles from rat liver: characterization, validation, and bile acid transport studies. J Biol Chem 259:9295-9301.
5. Fleischer S and Kervina M (1974) Subcellular fractionation of rat liver. Methods Enzymol 31: 6-41.
6. Gröer C, Brück S, Lai Y, Paulick A, Busemann A, Heidecke CD, Siegmund W, and Oswald S (2013) LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins. J Pharm Biomed Anal 85:253-261.
7. Harwood MD, Neuhoff S, Carlson GL, Warhurst G, and Rostami-Hodjegan A (2013) Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption. Biopharm Drug Dispos 34: 2-28.
8. Huber LA, Pfaller K, and Vietor I (2003) Organelle proteomics: implications for subcellular fractionation in proteomics. Circ Res 92:962-968.
9. Jamei M, Bajot F, Neuhoff S, Barter Z, Yang J, Rostami-Hodjegan A, and Rowland-Yeo K (2014) A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine. Clin Pharmacokinet 53:73-87.
10. Ji C, Tschantz WR, Pfeifer ND, Ullah M, and Sadagopan N (2012) Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues. Anal Chim Acta 717:67-76.
11. Jones HM, Barton HA, Lai Y, Bi YA, Kimoto E, Kempshall S, Tate SC, El-Kattan A, Houston JB, and Galetin A, et al. (2012) Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos 40:1007-1017.
12. Krüger M, Moser M, Ussar S, Thievessen I, Luber CA, Forner F, Schmidt S, Zanivan S, Fässler R, and Mann M (2008) SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 134:353-364.
13. Li N, Bi YA, Duignan DB, and Lai Y (2009) Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes. Mol Pharm 6:1180-1189.
14. Li N, Singh P, Mandrell KM, and Lai Y (2010) Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. Mol Pharm 7:630-641.
15. Lipscomb JC, Teuschler LK, Swartout JC, Striley CA, and Snawder JE (2003) Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver. Toxicol Mech Methods 13:45-51.
16. Miliotis T, Ali L, Palm JE, Lundqvist AJ, Ahnoff M, Andersson TB, and Hilgendorf C (2011) Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function. Drug Metab Dispos 39:2440-2449.
17. Neuhoff S, Yeo KR, Barter Z, Jamei M, Turner DB, and Rostami-Hodjegan A (2013) Application of permeability-limited physiologically-based pharmacokinetic models: part I-digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux. J Pharm Sci 102: 3145-3160.
18. Neville DM, Jr (1960) The isolation of a cell membrane fraction from rat liver. J Biophys Biochem Cytol 8:413-422.
19. Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, Decleves X, Scherrmann JM, Couraud PO, and Kubo Y, et al. (2013) Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm 10: 289-296.
20. Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, and Ebner T, et al. (2012) Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos 40:83-92.
21. Ohtsuki S, Uchida Y, Kubo Y, and Terasaki T (2011) Quantitative targeted absolute proteomicsbased ADME research as a new path to drug discovery and development: methodology,advantages, strategy, and prospects. J Pharm Sci 100:3547-3559.
22. Ong SE, Kratchmarova I, and Mann M (2003) Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J Proteome Res 2:173-181.
23. Prasad B, Evers R, Gupta A, Hop CE, Salphati L, Shukla S, Ambudkar SV, and Unadkat JD (2014) Interindividual variability in hepatic organic anion-Transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex. Drug Metab Dispos 42:78-88.
24. Prasad B, Lai Y, Lin Y, and Unadkat JD (2013) Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype. J Pharm Sci 102:787-793.
25. Prasad B and Unadkat JD (2014) Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics. AAPS J 16:634-648.
26. Qiu X, Bi YA, Balogh LM, and Lai Y (2013) Absolute measurement of species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) and its modulation in cultured hepatocytes. J Pharm Sci 102:3252-3263.
27. Seithel A, Glaeser H, Fromm MF, and König J (2008) The functional consequences of genetic variations in transporter genes encoding human organic anion-Transporting polypeptide family members. Expert Opin Drug Metab Toxicol 4:51-64.
28. Tang F, Horie K, and Borchardt RT (2002) Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Pharm Res 19:765-772.
29. Tucker TG, Milne AM, Fournel-Gigleux S, Fenner KS, and Coughtrie MW (2012) Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-Associated protein 2 in human liver and duodenum. Biochem Pharmacol 83:279-285.
30. Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, and Bergman A (2012) Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions. Pharm Res 29:2860-2873.
31. Varma MV, Lai Y, Kimoto E, Goosen TC, El-Kattan AF, and Kumar V (2013) Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide. Pharm Res 30:1188-1199.
32. Vildhede A, Karlgren M, Svedberg EK, Wisniewski JR, Lai Y, Norén A, and Artursson P (2014) Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactions. Drug Metab Dispos 42:1210-1218.
33. Wilson ZE, Rostami-Hodjegan A, Burn JL, Tooley A, Boyle J, Ellis SW, and Tucker GT (2003) Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. Br J Clin Pharmacol 56:433-440.
34. Yeo KR, Jamei M, and Rostami-Hodjegan A (2013) Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach. Expert Rev Clin Pharmacol 6:143-157.
35. Zhang Y, Li N, Brown PW, Ozer JS, and Lai Y (2011) Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples. Rapid Commun Mass Spectrom 25:1715-1724.